Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Kudo

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Vaccine|April 3, 2026
Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUSHaruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 8, 2026
Concomitant Diabetes Mellitus Diminishes the Efficacy of Left Atrial Additional Ablation Following Pulmonary Vein Isolation　- A Subanalysis of the EARNEST-PVI TrialYasuhiro Matsuda, Masaharu Masuda, Nobuaki Tanaka, et al.
Congenital Anomalies|August 8, 2018
Historical control data on developmental toxicity studies in ratsMakiko Kuwagata, Yuko Sakai, Sho Tanaka, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 2, 2025
Impact of renal function on the efficacy of low-voltage area ablation after pulmonary vein isolation: A sub-analysis of the SUPPRESS-AF trialYasuhiro Matsuda, Masaharu Masuda, Toshiaki Mano, et al.
Expert Review of Vaccines|January 30, 2024
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)Haruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Vaccine|April 3, 2026
Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUSHaruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 8, 2026
Concomitant Diabetes Mellitus Diminishes the Efficacy of Left Atrial Additional Ablation Following Pulmonary Vein Isolation　- A Subanalysis of the EARNEST-PVI TrialYasuhiro Matsuda, Masaharu Masuda, Nobuaki Tanaka, et al.
Congenital Anomalies|August 8, 2018
Historical control data on developmental toxicity studies in ratsMakiko Kuwagata, Yuko Sakai, Sho Tanaka, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 2, 2025
Impact of renal function on the efficacy of low-voltage area ablation after pulmonary vein isolation: A sub-analysis of the SUPPRESS-AF trialYasuhiro Matsuda, Masaharu Masuda, Toshiaki Mano, et al.
Expert Review of Vaccines|January 30, 2024
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)Haruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Pageof 6